Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them
申请人:Rossi Cristina
公开号:US20080207694A1
公开(公告)日:2008-08-28
Compounds of structure (I) having histone deacetylase (HDAC) inhibitor activity are described. The compounds are chemically characterised by the presence of hydroxamic acid, with zinc as chelator, and an aromatic nucleus connected by a linker in which either a bicyclic aromatic system or a piperidino ring are present.